en

PRODUCT DETAIL

Abiraterón Sandoz 250 mg filmom obalené tablety

Code 7929D
MA number 44/0185/21-S
Product Form: tbl flm 120x1x250 mg (blis.Al/OPA/Al/PVC-jednotliv.dáv.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Sandoz Pharmaceuticals d.d., Slovenia
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BX Other hormone antagonists and relate agents
L02BX03 Abiraterone
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 23.07.2021
Validity: 23.07.2026
PIL: PIL_Abiraterón Sandoz 250 mg_500 mg tbl flm_jún 2021.pdf  
SPC: SPC_Abiraterón Sandoz 250 mg_500 mg tbl flm_jún 2021.pdf  
Safety feature Yes
Data update: 02.08.2021
eu-flag.png sk-flag.png